In Silico Approach for Peptide Vaccine Design for CoVID 19

The currently surging SARS-COV-2 (or CoVID-19) is challenging the public health authorities worldwide. As of now there is no approved vaccine or drug available for the control of the viral disease. Therefore, non-pharmaceutical interventions (NPIs) are being used around the world to manage the spread of CoVID-19. In this article we used a computer-assisted vaccine design (CAVD) approach to develop a set of most probable peptide vaccine candidates which can be tested for their efficacy by wet lab experiments.